Effects of Melatonin on Sleep Quality in Patients With Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review and Meta-Analysis on Randomized Controlled Trials Studies
Abstract
Background and Objective Rapid eye movement (REM) sleep behavior disorder (RBD) is a sleep disorder characterized by REM sleep without atonia, resulting in physical movements that interrupt sleep quality. Melatonin has been suggested as an alternative therapy for patient intolerant to clonazepam. A systematic review and meta-analysis were conducted to evaluate the effectiveness of melatonin in improving sleep quality in RBD patients, analyzing sleep parameters both objectively with polysomnography (PSG) and subjectively with sleep questionnaires.Methods This systematic review and meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines and the Cochrane Handbook. A comprehensive search was performed across various databases (PubMed, Web of Science, Scopus, Taylor and Francis, ProQuest). Study quality was assessed using the Cochrane Risk of Bias 2.0 tool, and data were analyzed using R Studio.Results Statistically, the results of PSG analysis showed a significant improvement in the sleep of RBD patients receiving melatonin, characterized by a decrease in wakefulness after sleep onset (WASO) (mean difference [MD]=-11.17, 95% confidence interval [CI] [-13.35; -8.99], p<0.0001) and sleep onset latency (SOL) (MD=-7.05, 95% CI [-11.40; -2.69], p=0.0015), as well as an increase in time in REM sleep (MD=3.93, 95% CI [2.88; 4.99], p<0.00001). However, evaluation using sleep questionnaires overall did not show significant results…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.